Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
54.8M
-
Number of holders
-
42
-
Total 13F shares, excl. options
-
8.62M
-
Shares change
-
+8.61M
-
Total reported value, excl. options
-
$160M
-
Value change
-
+$160M
-
Number of buys
-
41
-
Price
-
$18.61
Significant Holders of Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share (CARA) as of Q1 2014
42 filings reported holding CARA - Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q1 2014.
Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share (CARA) has 42 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.62M shares
of 54.8M outstanding shares and own 15.73% of the company stock.
Largest 10 shareholders include RHO CAPITAL PARTNERS INC (2.67M shares), FMR LLC (1.43M shares), Lloyds Banking Group plc (890K shares), FRANKLIN RESOURCES INC (648K shares), JPMORGAN CHASE & CO (364K shares), JENNISON ASSOCIATES LLC (354K shares), WALL STREET ASSOCIATES (325K shares), TIVERTON ASSET MANAGEMENT LLC (250K shares), WELLINGTON MANAGEMENT CO LLP (185K shares), and GREAT POINT PARTNERS LLC (178K shares).
This table shows the top 42 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.